{"text": "$LLY Top analyst price target for next week..~\n\ud83d\udd17https://t.co/OCdbxK92DM", "author_id": "1548877026488373249", "created_at": "2022-12-07T11:22:27.000Z", "edit_history_tweet_ids": ["1600450661187219456"], "id": "1600450661187219456"}
{"id": "1600620445627056129", "edit_history_tweet_ids": ["1600620445627056129"], "created_at": "2022-12-07T22:37:06.000Z", "text": "We are glad to help this member reach his goal. Check out what he said in his updated review of our server  https://t.co/uZOoPk4ZQ8\n\n$CMCSA $PEP $SAP $XOM $ABBV $ABT $TM $CRM $ORCL $CVX $ASML $LLY $TMO $AMGN $AZN $NKECHL $COST $MCD $ACN $BMY $DHR $NEE $SNY $CHTR $MDT $TMUS https://t.co/DSmq3ZBHPl", "author_id": "1570891082032123907"}
{"text": "N/A &amp; $LLY\n\ud83c\udde9\ud83c\uddea \ud83c\uddfa\ud83c\uddf8\nBoehringer Ingelheim &amp; Eli Lilly\n\nPhase III trial demonstrated Jardiance\u00ae is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes\n\nhttps://t.co/UJddWeWqQ8 https://t.co/F0peqxBg3m", "author_id": "1384738758587817986", "created_at": "2022-12-07T10:21:36.000Z", "edit_history_tweet_ids": ["1600435349448052736"], "id": "1600435349448052736"}
{"id": "1600519294504222720", "edit_history_tweet_ids": ["1600519294504222720"], "created_at": "2022-12-07T15:55:10.000Z", "text": "Today Top Flow in #healthcare sector, Buy Flow &amp; Sell Flow $CI $ABC $MDT $THC $BMY $VRTX $ZTS $LLY $UNH $MCK $PFE $BDX $MRK $ABT $PKI $JNJ $TMO $ISRG $EW $GILD #stock #stocks #StockMarket #Investment #investing #HealthTech https://t.co/Gr3YvQQ4OY https://t.co/RrDuwNvARd", "author_id": "4584354895"}
